PMK S005

Drug Profile

PMK S005

Alternative Names: PMK-N01GI2; PMK-S005

Latest Information Update: 16 Jul 2016

Price : $50

At a glance

  • Originator PharmaKing
  • Class Antiulcers
  • Mechanism of Action
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Phase II Gastric ulcer
  • No development reported Gastritis

Most Recent Events

  • 16 Jul 2016 No recent reports of development identified for phase-I development in Gastritis(In volunteers) in South Korea (PO)
  • 01 Sep 2014 Phase-II clinical trials in Gastric ulcer (Prevention, Recurrent) in South Korea (PO)
  • 31 Dec 2012 Phase-I clinical trials in Gastritis (in volunteers) in South Korea (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top